Trial Condition(s):

Healthy, Postmenopause

Fat distribution in healthy early postmenopausal women

Bayer Identifier:

91161

ClinicalTrials.gov Identifier:

NCT00335218

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The aim of this study is to explore the effects of hormone replacement therapy with EV/DNG on abdominal fat distribution measured by magnetic resonance imaging.

Inclusion Criteria
- Healthy early postmenopausal women
 - BMI between 25 and 30
Exclusion Criteria
- Contra-indication(s) for hormone treatment
 - Metabolic diseases
 - Concomitant medication with influence on lipid metabolism

Trial Summary

Enrollment Goal
67
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
Yes
Products
Climodien, Lafamme (EV/DNG, BAY86-5027)
Accepts Healthy Volunteers
Yes

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Dr. Ewald Boschitsch

Wien, Austria, 1060

Status
Completed
 
Locations

Allgemeines Krankenhaus der Stadt Wien Universitätskliniken

Wien, Austria, 1090

Status
Completed
 
Locations

Dr. Wolfgang Bartl

Wien, Austria, 1200

Status
Completed
 

Trial Design